阿尔茨海默病病理学和辅助纳米疗法对其治疗干预的方法
Anuvab Dey1, Subhrojyoti Ghosh2, Ramya Lakshmi Rajendran3
1Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, North Guwahati 781039, Assam, India.
International journal of molecular sciences
|September 14, 2024
概括
对阿尔茨海默病 (AD) 提供有希望的解决方案,这是一个渐进的神经退行性疾病. 这些先进的纳米系统增强了跨越血脑屏障的药物输送,以改善AD的诊断和治疗.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一个日益严重的全球健康问题,其特点是β-粉样蛋白斑块和神经纤维细胞,导致认知能力下降.
- 目前对阿尔茨海默病发病的理解主要依赖于粉样蛋白和蛋白假设,相关的生物标志物对疾病进展至关重要.
- 现有的阿尔茨海默病的诊断和治疗策略面临着重大的局限性.
研究的目的:
- 为提供有关阿尔茨海默氏症病原的全面概述.
- 探索纳米异能剂在阿尔茨海默病诊断和治疗中的进步和潜力.
- 讨论当前AD管理方法的缺陷,并突出纳米激光在个性化医学中的作用.
主要方法:
- 关于阿尔茨海默氏症病原学的当前文献的综述.
- 对药物输送和治疗干预的纳米疗法策略的分析.
- 评估纳米颗粒系统的血脑屏障透和准.
主要成果:
- 纳米异能药物能够增强药物输送,向治疗和AD的药物动力学监测.
- 纳米系统对神经毛囊内皮细胞和血脑屏障具有很高的亲和力,有助于早期诊断和治疗.
- 在nanotheranostics的进步为AD提供了个性化和精确医学的道路.
结论:
- 在解决阿尔茨海默氏病的挑战方面,纳米体代表了重大进步.
- 这些技术有望改善早期诊断,向药物输送和整体治疗疗效.
- 需要进行进一步的研究,以解决与纳米异常方法相关的潜在缺点,副作用和安全问题.
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107


